EUVIMEDEUVIMED entdecken
Open Access

Impact of Significant Hemoglobin Drop Without Bleeding in Patients Undergoing Transcatheter Aortic Valve Replacement

Pavan Reddy iD, Ilan Merdler, Cheng Zhang, Matteo Cellamare, Itsik Ben-Dor, Lowell F Satler iD, Toby Rogers iD, Hector M Garcia-Garcia iD, Ron Waksman iD

Journal of the American Heart Association · 04.06.2024 · 13 (11)

DOI: 10.1161/jaha.123.032291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 04.06.2024. Verfasst von Pavan Reddy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Interventional Cardiology MedStar Washington Hospital Center Washington DC USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Hemoglobins, Hospital Mortality, Aortic Valve Stenosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Hemoglobin (Hgb) drop without bleeding is common among patients undergoing transcatheter aortic valve replacement; however, the clinical implications of significant Hgb drop have not been fully evaluated. Methods and Results Consecutive patients undergoing transcatheter aortic valve replacement at our institution from 2011 to 2021 were retrospectively reviewed. Three groups were assessed: no Hgb drop and no bleed (NoD‐NoB [reference group]), Hgb drop with bleed, and Hgb drop and no bleed (D‐NoB). Hgb drop was defined as ≥3 g/dL decrease from pre‐ to post‐transcatheter aortic valve replacement. Outcomes of interest were in‐hospital death and 1‐year all‐cause mortality. A total of 1851 cases with complete Hgb data were included: NoD‐NoB: n=1579 (85.3%); D‐NoB: n=49 (2.6%); Hgb drop with bleed: n=223 (12.6%). Compared with NoD‐NoB, the D‐NoB group was older (81.1 versus 78.9 years of age) with higher preprocedure Hgb (12.9 versus 11.7 g/dL). In‐hospital death rate was higher among patients with D‐NoB versus NoD‐NoB (4.5% versus 0.8%, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementHemoglobinsHospital MortalityAortic Valve StenosisHumansMaleFemaleAged, 80 and overAgedRetrospective StudiesRisk FactorsTreatment OutcomeRisk Assessment

Stichwörter der Autor:innen

TAVRbleedingrisk stratification

Substanzen

Hemoglobins

Autor:innen und Institutionen

  • Section of Interventional Cardiology MedStar Washington Hospital Center Washington DC USA.
  • Cardiovascular Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health Bethesda MD USA.

ORCID-Profile: Pavan Reddy, Lowell F Satler, Toby Rogers, Hector M Garcia-Garcia, Ron Waksman

Zitieren

APA

Reddy, P., Merdler, I., Zhang, C., Cellamare, M., Ben-Dor, I., Satler, L. F., Rogers, T., Garcia-Garcia, H. M., & Waksman, R. (2024). Impact of Significant Hemoglobin Drop Without Bleeding in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of the American Heart Association, 13(11). https://doi.org/10.1161/jaha.123.032291

Vancouver

Reddy P, Merdler I, Zhang C, Cellamare M, Ben-Dor I, Satler LF, et al. Impact of Significant Hemoglobin Drop Without Bleeding in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of the American Heart Association. 2024;13(11). doi:10.1161/jaha.123.032291

BibTeX
@article{Reddy2024,
  author = {Reddy, Pavan and Merdler, Ilan and Zhang, Cheng and Cellamare, Matteo and Ben-Dor, Itsik and Satler, Lowell F and Rogers, Toby and Garcia-Garcia, Hector M and Waksman, Ron},
  title = {Impact of Significant Hemoglobin Drop Without Bleeding in Patients Undergoing Transcatheter Aortic Valve Replacement},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {11},
  doi = {10.1161/jaha.123.032291}
}
Kostenlos starten →